<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04739267</url>
  </required_header>
  <id_info>
    <org_study_id>1000-2</org_study_id>
    <nct_id>NCT04739267</nct_id>
  </id_info>
  <brief_title>Acute Coronary Syndrome CardioFlux TM Study</brief_title>
  <acronym>ACCMED</acronym>
  <official_title>The Acute Coronary Syndrome Accelerated CardioFlux TM Magnetocardiography-based Early Disposition Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Genetesis Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Genetesis Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately 16.5 million people suffer from coronary artery disease (CAD) and about 10&#xD;
      million present each year to emergency departments with symptoms like chest pain and&#xD;
      shortness of breath, commonly suggestive of acute coronary syndrome (ACS). To clinically&#xD;
      assess ACS risk in these patients, there are typically 2-6 hours of emergency room&#xD;
      evaluation, followed by 6-42 hours of an observation period prior to discharge. The clinical&#xD;
      pathway includes: 1) 1-3 ECG's; 2) serial troponins (1 and 3 hours vs 1 and 6 hours); and 3)&#xD;
      other pertinent diagnostic information, including but not limited to echocardiography, stress&#xD;
      testing and/or CT Angiography. Patients who are evaluated, have presented with a low risk for&#xD;
      ACS, and maintain negative diagnostic results can potentially be discharged within 6 hours.&#xD;
      However, 20%-40% of patients who fall into indeterminate diagnostic categories will require&#xD;
      longer observation periods or admission of 12-48 hours which result in the use of expensive&#xD;
      imaging and provocative testing, such as stress testing. The purpose of ACCMED is to measure&#xD;
      the efficacy and diagnostic accuracy of CardioFlux as an adjunctive diagnostic tool to&#xD;
      rule-in/rule-out ACS in patients with symptoms suggestive of ACS, and evaluate the clinical&#xD;
      and economic advantages of incorporating MCG into the triage pathway.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 27, 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Specificity statistics</measure>
    <time_frame>6 months</time_frame>
    <description>analyzing the specificity of CardioFlux</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy Statistics</measure>
    <time_frame>6 months</time_frame>
    <description>analyzing the accuracy of CardioFlux</description>
  </primary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Acute Myocardial Injuries</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CardioFlux</intervention_name>
    <description>Not an intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients presenting to the ED with symptoms of potential ACS and fitting the&#xD;
        eligibility/exclusion criteria will be approached for accrual&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. ≥ 18 years of age at the time of enrollment.&#xD;
&#xD;
          2. Patient presenting with symptoms and signs consistent with ACS who do not have&#xD;
             evidence of STEMI and/or hemodynamic instability on admission.&#xD;
&#xD;
          3. Consents to having an MCG-CF study scan.&#xD;
&#xD;
          4. Modified HEART score of 3-7&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. &lt; 18 years of age&#xD;
&#xD;
          2. Patients unable to fit into device&#xD;
&#xD;
          3. Non-ambulatory patients&#xD;
&#xD;
          4. Positive response on MCG Pre-Screening Form&#xD;
&#xD;
          5. AF with RVR &gt;120 bpm and/or hemodynamic instability&#xD;
&#xD;
          6. Patients with claustrophobia or unable to lie supine for up to 5 minutes&#xD;
&#xD;
          7. Pregnant women&#xD;
&#xD;
          8. Poor candidate for follow-up (e.g. no access to phone)&#xD;
&#xD;
          9. Prisoners&#xD;
&#xD;
         10. Repeat participants&#xD;
&#xD;
         11. STEMI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Anthony Senagore, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Genetesis Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anthony Senagore, M.D.</last_name>
    <phone>513-715-5045</phone>
    <email>anthony@genetesis.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samantha Legreaux, M.S.</last_name>
    <phone>513-715-5045</phone>
    <email>sam.legreaux@genetesis.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Genetesis Facility</name>
      <address>
        <city>Mason</city>
        <state>Ohio</state>
        <zip>45040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sam Legreaux, M.S.</last_name>
      <phone>513-715-5045</phone>
      <email>sam.legreaux@genetesis.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. Review. Erratum in: Circulation. 2017 Mar 7;135(10 ):e646. Circulation. 2017 Sep 5;136(10 ):e196.</citation>
    <PMID>28122885</PMID>
  </reference>
  <reference>
    <citation>Yang G, Yao Y, Du Y, Huang J. Cardiac troponin had limited diagnostic value for acute myocardial infarction in renal insufficiency: a meta-analysis. Biomark Med. 2020 Apr;14(6):481-493. doi: 10.2217/bmm-2019-0339. Epub 2020 Apr 9.</citation>
    <PMID>32270694</PMID>
  </reference>
  <reference>
    <citation>Chiang CH, Chiang CH, Lee GH, Gi WT, Wu YK, Huang SS, Yeo YH, Giannitsis E, Lee CC. Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis. Heart. 2020 Jul;106(13):985-991. doi: 10.1136/heartjnl-2019-316343. Epub 2020 Apr 3.</citation>
    <PMID>32245882</PMID>
  </reference>
  <reference>
    <citation>Lee CC, Huang SS, Yeo YH, Hou YT, Park JY, Inoue K, Hsu WT. High-sensitivity-cardiac troponin for accelerated diagnosis of acute myocardial infarction: A systematic review and meta-analysis. Am J Emerg Med. 2020 Jul;38(7):1402-1407. doi: 10.1016/j.ajem.2019.11.035. Epub 2019 Dec 28.</citation>
    <PMID>31932131</PMID>
  </reference>
  <reference>
    <citation>Madsen TE, Stewart M, Smyres C, Beal A, Hamilton D, Vlasic K, Oates A. Significance of an Indeterminate Troponin I in Patients Evaluated for Chest Pain in an Emergency Department Observation Unit. Crit Pathw Cardiol. 2015 Dec;14(4):146-9. doi: 10.1097/HPC.0000000000000054.</citation>
    <PMID>26569654</PMID>
  </reference>
  <reference>
    <citation>Madsen T, Perkins R, Holt B, Carlson M, Steenblik J, Bossart P, Hartsell S. Emergency Department Observation Unit Utilization Among Older Patients With Chest Pain. Crit Pathw Cardiol. 2019 Mar;18(1):19-22. doi: 10.1097/HPC.0000000000000166.</citation>
    <PMID>30747761</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 27, 2021</study_first_submitted>
  <study_first_submitted_qc>February 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 4, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ischemia</keyword>
  <keyword>Cardiovascular Disease</keyword>
  <keyword>MCG</keyword>
  <keyword>CardioFlux</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

